Latest Market Launch News

Page 4 of 8
Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.
Ada Torres
Ada Torres
29 Oct 2025
Adslot Ltd reports solid progress in Q1 FY26, highlighting growth in its StoreFront and Marketplace platforms alongside a successful $989,000 capital raise to fuel expansion.
Sophie Babbage
Sophie Babbage
29 Oct 2025
LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.
Ada Torres
Ada Torres
29 Oct 2025
IODM Limited has reported a record-breaking first quarter for FY26, with cash receipts soaring 76% year-on-year, driven predominantly by explosive growth in its UK Education segment. The company also made strategic advances in North America and Japan, setting the stage for broader global expansion.
Sophie Babbage
Sophie Babbage
28 Oct 2025
Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.
Victor Sage
Victor Sage
23 Oct 2025
Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.
Ada Torres
Ada Torres
22 Oct 2025
Nexsen Limited has initiated clinical trials for its StrepSure® GBS Rapid Sensor, a next-generation diagnostic device aimed at improving maternal health outcomes. The trial's success could pave the way for regulatory approval and early market penetration by the second half of 2026.
Ada Torres
Ada Torres
21 Oct 2025
EVE Health Group has raised $1.1 million to accelerate the commercial rollout of its innovative pharmaceutical products Dyspro and Libbo, signaling strong investor confidence in its growth strategy.
Victor Sage
Victor Sage
9 Oct 2025
Orthocell has appointed its first Canadian distributor for Remplir, its innovative nerve repair device, ahead of an official launch at a major surgical conference in Vancouver. The move marks a significant step in expanding the product’s international footprint.
Ada Torres
Ada Torres
30 Sept 2025
Dimerix Limited’s lead drug candidate DMX-200 has been granted Orphan Drug Designation in Japan for treating Focal Segmental Glomerulosclerosis (FSGS), enhancing its regulatory and commercial prospects in a key market.
Ada Torres
Ada Torres
30 Sept 2025
ReNerve Limited has launched its Empliq tissue product range in the US, marking a strategic expansion into the growing dermal and amniotic tissue market. The launch complements its existing nerve repair portfolio and sets the stage for further growth.
Ada Torres
Ada Torres
22 Sept 2025
Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.
Ada Torres
Ada Torres
15 Sept 2025